Callan Family Office, LLC Harvard Bioscience Inc Transaction History
Callan Family Office, LLC
- $3.14 Trillion
- Q3 2025
A detailed history of Callan Family Office, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 29,844 shares of HBIO stock, worth $19,398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,844
Previous 29,844
-0.0%
Holding current value
$19,398
Previous $13.2 Million
1.19%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HBIO
# of Institutions
65Shares Held
19.5MCall Options Held
54KPut Options Held
0-
Amh Equity LTD4.05MShares$2.63 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.85 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.05MShares$1.33 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$1.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$695,2980.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $27.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...